| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 59651-590-01 | 59651-590 | HUMAN PRESCRIPTION DRUG | Pyrimethamine | Pyrimethamine | TABLET | ORAL | 20221025 | N/A | ANDA | ANDA216983 | Aurobindo Pharma Limited | PYRIMETHAMINE | 25 mg/1 | 100 TABLET in 1 BOTTLE (59651-590-01) |
| 59651-590-30 | 59651-590 | HUMAN PRESCRIPTION DRUG | Pyrimethamine | Pyrimethamine | TABLET | ORAL | 20221025 | N/A | ANDA | ANDA216983 | Aurobindo Pharma Limited | PYRIMETHAMINE | 25 mg/1 | 30 TABLET in 1 BOTTLE (59651-590-30) |
| 72603-262-01 | 72603-262 | HUMAN PRESCRIPTION DRUG | Pyrimethamine | Pyrimethamine | TABLET | ORAL | 20241001 | N/A | ANDA | ANDA216983 | NorthStar Rx LLC | PYRIMETHAMINE | 25 mg/1 | 30 TABLET in 1 BOTTLE (72603-262-01) |
| 72603-262-02 | 72603-262 | HUMAN PRESCRIPTION DRUG | Pyrimethamine | Pyrimethamine | TABLET | ORAL | 20241001 | N/A | ANDA | ANDA216983 | NorthStar Rx LLC | PYRIMETHAMINE | 25 mg/1 | 100 TABLET in 1 BOTTLE (72603-262-02) |